Follow-up of patients with non-small cell lung cancer undergoing full resection. Should surgeons be in charge?;Seguimiento de los pacientes con cáncer de pulmón no microcítico sometidos a resección completa. ¿Deben hacerlo los cirujanos?
Cirugía del carcinoma broncogénico en España. Estudio descriptivo
Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S). Cirugía del carcinoma broncogénico en España. Estudio descriptivo. Arch Bronconeumol 1995; 31: 303-309.
Malignant disease appearing late after operation for T1N0 non-small-cell lung cancer
The Lung Cancer Study Group. Malignant disease appearing late after operation for T1N0 non-small-cell lung cancer. J Thorac Cardiovasc Surg 1993; 106: 1.053-1.058.
Is follow-up of lung cancer patients after resection medically indicated and cost-effective?
Walsh GL, O'Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995; 60: 1.563-1.572.
Dartevelle P, Khalife J. Surgical approach to local recurrence and the second primary lesion. En: Delarue NC, Eschapasse H, editores. Lung cancer. International trends in general thoracic surgery. Vol I. Filadelfia: W.U. Saunders, 1985; 153-163.
Impact of follow-up testing on survival and health related quality of life in breast cancer patients. A multicenter randomized controlled trial
The GIVIO Investigators. Impact of follow-up testing on survival and health related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994; 271: 1.587-1.592.
Comorbilidad en el carcinoma broncogénico con tratamiento quirúrgico
GCCB-SEPAR (presentado por A. López-Encuentra)
GCCB-SEPAR (presentado por A. López-Encuentra). Comorbilidad en el carcinoma broncogénico con tratamiento quirúrgico. Arch Bronconeumol 1995; 31 (Supl 1): 19.